Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2002 | 06-2002 | 03-2002 | 12-2001 | 09-2001 | |
| Sales | 30,204 | 26,441 | 25,916 | 25,088 | 23,750 |
| Cost of Goods | 12,611 | 9,465 | 9,528 | 9,957 | 9,153 |
| Gross Profit | 17,593 | 16,976 | 16,388 | 15,131 | 14,597 |
| Operating Expenses | 16,612 | 11,951 | 11,591 | 11,376 | 11,014 |
| Operating Income | 1,592 | 5,490 | 5,325 | 4,712 | 3,736 |
| Interest Expense | 10 | 7 | 0 | 0 | 0 |
| Other Income | 821 | 1,055 | 970 | 754 | 652 |
| Pre-tax Income | 2,403 | 6,538 | 6,295 | 5,466 | 4,388 |
| Income Tax | 840 | 2,289 | 2,204 | -11,916 | 365 |
| Net Income Continuous | 1,563 | 4,249 | 4,091 | 17,382 | 4,023 |
| Net Income Extraordinary | N/A | N/A | N/A | N/A | -243 |
| Net Income | $1,563 | $4,249 | $4,091 | $17,625 | $3,780 |
| EPS Basic Total Ops | 0.03 | 0.08 | 0.07 | 0.37 | 0.07 |
| EPS Basic Continuous Ops | 0.03 | 0.07 | 0.07 | 0.37 | 0.08 |
| EPS Diluted Total Ops | 0.03 | 0.07 | 0.07 | 0.32 | 0.07 |
| EPS Diluted Continuous Ops | 0.03 | 0.07 | 0.07 | 0.30 | 0.07 |
| EBITDA(a) | $3,557 | $7,131 | $6,904 | $6,361 | $5,489 |